tiprankstipranks
Trending News
More News >
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market

Arcutis Biotherapeutics (ARQT) Income Statement

Compare
943 Followers

Arcutis Biotherapeutics Income Statement

Last quarter (Q3 2025), Arcutis Biotherapeutics's total revenue was $99.22M, an increase of 121.69% from the same quarter last year. In Q3, Arcutis Biotherapeutics's net income was $7.41M. See Arcutis Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 196.54M$ 59.61M$ 3.69M$ 0.00$ 0.00
Gross Profit
$ 177.41M$ 54.62M$ 2.93M$ -763.00K$ -455.00K
Operating Expenses
$ 305.81M$ 295.72M$ 304.56M$ 206.53M$ 136.19M
Depreciation and Amortization
$ 2.60M$ 1.88M$ 1.25M$ 763.00K$ 455.00K
EBITDA
$ -109.63M$ -227.43M$ -294.55M$ -205.59M$ -135.22M
Operating Income
$ -128.40M$ -241.10M$ -301.63M$ -206.53M$ -136.65M
Other Income/Expenses
$ -10.99M$ -17.93M$ -9.83M$ 173.00K$ 967.00K
Pretax Income
$ -139.39M$ -259.03M$ -311.46M$ -206.36M$ -135.68M
Net Income
$ -140.04M$ -262.14M$ -311.46M$ -206.36M$ -135.68M
Per Share Metrics
Basic EPS
$ -1.16$ -3.78$ -5.66$ -4.17$ -3.80
Diluted EPS
$ -1.16$ -3.78$ -5.66$ -4.17$ -3.80
Weighted Average Shares Outstanding
120.96M 69.31M 55.03M 49.41M 35.67M
Weighted Average Shares Outstanding (Diluted)
120.96M 69.31M 55.03M 49.41M 35.67M
Currency in USD

Arcutis Biotherapeutics Earnings and Revenue History